Long-term Efficacy of Erenumab in Patients with Chronic Migraine Who Failed Prior Prophylactic Treatment

被引：0
|
作者：
Ashina, M. [1 ]
Tepper, S. J. [2 ]
Brandes, J. [3 ]
Boudreau, G. [4 ]
Dolezil, D. [5 ]
Klatt, J. [6 ]
Zhang, F. [7 ]
Cheng, S. [7 ]
Mikol, D. D. [7 ]
机构：
[1] Rigshosp Glostrup, Glostrup, Hovedstaden, Denmark
[2] Dartmouth Hitchcock Med Ctr, Dept Neurol, Lebanon, NH 03766 USA
[3] Nashville Neurosci Grp, Nashville, TN USA
[4] Ctr Traitement Neurol, Montreal, PQ, Canada
[5] Prague Headache Ctr, Prague, Jihocesky Kraj, Czech Republic
[6] Novartis Pharma AG, Basel, Basel Stadt, Switzerland
[7] Amgen Inc, Thousand Oaks, CA USA
来源：
HEADACHE | 2018年 / 58卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PF106LB
引用
收藏
页码：1296 / 1297
页数：2
相关论文
共 50 条
  • [1] Long-term efficacy of erenumab in patients with chronic migraine who failed prior prophylactic treatment
    Ashina, Messoud
    Tepper, Stewart J.
    Brandes, Jan L.
    Reuter, Uwe
    Boudreau, Guy
    Dolezil, David
    Klatt, Jan
    Zhang, Feng
    Cheng, Sunfa
    Mikol, Daniel D.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [2] Long-term Efficacy of Erenumab in Patients With Chronic Migraine Who Failed ≥3 Prior Prophylactic Treatments
    Weatherall, Mark
    Gantenbein, Andreas R.
    Ritter, Shannon
    Snellman, Josefin
    Klatt, Jan
    Mikol, Daniel D.
    CEPHALALGIA, 2019, 39 : 240 - 241
  • [3] Long-term efficacy of erenumab in patients with episodic migraine who have failed prior preventive migraine therapies
    Reuter, U.
    Schwedt, T.
    Kudrow, D.
    Paemeleire, K.
    Zhang, F.
    Klatt, J.
    Picard, H.
    Chou, D.
    Mikol, D. D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 637 - 637
  • [4] Long-term Efficacy of Erenumab in Patients With Episodic Migranie Who Have Failed Prior Preventive Migraine Therapies
    Reuter, Uwe
    Schwedt, Todd J.
    Kudrow, David
    Paemeleire, Koen
    Zhang, Feng
    Klatt, Jan
    Picard, Hernan
    Chou, Denise E.
    Mikol, Daniel D.
    NEUROLOGY, 2019, 92 (15)
  • [5] Long-term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysis
    Ashina, Messoud
    Tepper, Stewart J.
    Brandes, Jan Lewis
    Reuter, Uwe
    Boudreau, Guy P.
    Weatherall, Mark
    Gantenbein, Andreas R.
    Dolezil, David
    Klatt, Jan
    Wang, Andrea
    Karanam, Ananda Krishna
    Cheng, Sunfa
    Mikol, Daniel D.
    HEADACHE, 2022, 62 (05): : 624 - 633
  • [6] How effective is erenumab for patients with chronic migraine who failed onabotulinum toxin type A as prophylactic treatment?
    Proot, Pascal
    CEPHALALGIA, 2019, 39 (1_SUPPL) : 411 - 412
  • [7] Long-term Efficacy of Erenumab in Chronic Migraine Patients with Acute Medication Overuse
    Tepper, S. J.
    Lipton, R. B.
    Silberstein, S. D.
    Kudrow, D.
    Ashina, M.
    Dodick, D. W.
    Zhang, F.
    Cheng, S.
    Mikol, D. D.
    HEADACHE, 2018, 58 (08): : 1298 - 1300
  • [8] The efficacy of lomerizine in the long-term prophylactic treatment of migraine
    Imai, N
    Konishi, T
    Suzuki, Y
    Serizawa, M
    Okabe, T
    Hamaguchi, K
    CEPHALALGIA, 2005, 25 (10) : 938 - 938
  • [9] Long-Term Efficacy of Fremanezumab in Chronic and Episodic Migraine Patients Who Failed at Least One Prior Migraine Preventive Medication: Results of a 1-Year Study
    Winner, Paul K.
    Freeman, Marshall C.
    Cohen, Joshua M.
    Yang, Ronghua
    Ning, Xiaoping
    Ortega, Mario
    ANNALS OF NEUROLOGY, 2019, 86 : S168 - S169
  • [10] Long-Term Efficacy of Fremanezumab in Chronic and Episodic Migraine Patients Who Failed at Least One Prior Migraine Preventive Medication: Results of a 1-Year Study
    Winner, P. K.
    Freeman, M. C.
    Cohen, J. M.
    Yang, R.
    Ning, X.
    HEADACHE, 2019, 59 : 118 - 119
12345